Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke.

Catriona J CunninghamRaymond WongJack BarringtonSabrina TamburranoEmmanuel PinteauxStuart M Allan

Published in: Stem cell research & therapy (2020)

Our results show for the first time that the administration of conditioned medium from IL-1α-primed MSCs leads to improvements in behavioural outcomes independently of neuroprotection.

Keyphrases

mesenchymal stem cells
umbilical cord
bone marrow
brain injury
type diabetes
cerebral ischemia
skeletal muscle
combination therapy